COR2ED The Heart of Medical Education
Our COR2ED channel brings together world-renowned medical experts to discuss and provide clear guidance on the latest scientific and clinical insights in various therapeutic areas, including oncology, cardiology, hemostasis, rare diseases, hemato-oncology, and endocrinology. At COR2ED, we are committed to providing balanced and evidence-based independent medical education to support healthcare ...
read more ↘ professionals in enhancing patient care. Many of our videos are created in collaboration with medical societies and patient advocacy groups.
↖ read less
read more ↘ professionals in enhancing patient care. Many of our videos are created in collaboration with medical societies and patient advocacy groups.
↖ read less
Playback speed
10 seconds
ESMO 2024 Summary: BRAF-Altered Lung Cancer
24 views
October 25, 2024
Prof. Planchard and Dr Cappuzzo share their views on the latest data on BRAF-altered lung cancer presented at the ESMO 2024 congress.
Watch and listen as the experts reveal what they consider to be the key clinical takeaways from the following NSCLC trials:
- PHAROS
- IFCT-1904 ENCO-BRAF
- 1L IO vs BRAF and MEK inhibitors
- MoST
Professors Stintzing and Dummer discuss BRAF-altered colorectal and other cancers in a separate ‘Update From ESMO’ video. Find it here, along with several other ESMO updates across multiple tumour types
Subscribe to the COR2ED channel above to be the first to hear about new Independent Medical Education programmes as they are released.
Follow LUNG CONNECT on social media:
X
LinkedIn
This content is intended for healthcare professionals outside of the UK only.
Published September 2024
The medical experts in this video are expressing their own views and not those of COR2ED, Supporters or their institution. This video is supported by an Independent Education Grant from Pierre Fabre.
This video was developed by cor2ed.com
Watch and listen as the experts reveal what they consider to be the key clinical takeaways from the following NSCLC trials:
- PHAROS
- IFCT-1904 ENCO-BRAF
- 1L IO vs BRAF and MEK inhibitors
- MoST
Professors Stintzing and Dummer discuss BRAF-altered colorectal and other cancers in a separate ‘Update From ESMO’ video. Find it here, along with several other ESMO updates across multiple tumour types
Subscribe to the COR2ED channel above to be the first to hear about new Independent Medical Education programmes as they are released.
Follow LUNG CONNECT on social media:
X
This content is intended for healthcare professionals outside of the UK only.
Published September 2024
The medical experts in this video are expressing their own views and not those of COR2ED, Supporters or their institution. This video is supported by an Independent Education Grant from Pierre Fabre.
This video was developed by cor2ed.com
Comments 0
Login to view comments.
Click here to Login
Oncology